Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
D
D

DardenRestaurants

Balita

Reuters - 5 araw ang nakaraan

U.S. CoreCivic, Eli Lilly, 40

U.S. RESEARCH ROUNDUP-CoreCivic, Eli Lilly, WD-40 July 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CoreCivic , Eli Lilly and WD -40, on Thursday. HIGHLIGHTS * Antero Resources Corp AR.N : Gerdes Energy Research raises to buy from neutral * CoreCivic Inc CXW.N : Jonestrading initiates coverage with hold rating * Costco Wholesale Corp COST.O : Jefferies raises target price to $1050 from $860 * Eli Lilly LLY.N :
C
F
E
E
E
I
D
Reuters - 4 linggo ang nakaraan

Street View: Darden 'stays the course' in challenging backdrop with Q4 profit beat

BUZZ-Street View: Darden 'stays the course' in challenging backdrop with Q4 profit beat ** Olive Garden owner Darden Restaurants DRI.N reported upbeat fourth-quarter profit, helped by lower input costs, including labor ** At least three brokerages raised PT on the stock; their median PT is $175 - LSEG DARDEN BENEFITS FROM MODERATE PRICING, HIGH SER
D
Reuters - 4 linggo ang nakaraan

U.S. CME Group, Ingersoll Rand, Winnebago Industries

U.S. RESEARCH ROUNDUP-CME Group, Ingersoll Rand, Winnebago Industries June 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CME Group, Ingersoll Rand and Winnebago Industries, on Friday. HIGHLIGHTS * CME Group Inc CME.O : JP Morgan cuts to underweight from neutral * Ingersoll Rand Inc IR.N : Jefferies resumes coverage with buy rating; PT $110 * Nike Inc NKE.N : Oppenheimer raises to outperform from perform * Sarept
A
A
C
K
M
M
N
N
G
I
A
D
Reuters - 4 linggo ang nakaraan

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hit record highs on Thursday, boosted by strong gains in Nvidia, while investors assessed recent economic data and commentary from Federal Reserve officials to gauge the timing of interest-rate cuts this year.
G
K
M
N
U
U
D
A
D
Reuters - 4 linggo ang nakaraan

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The benchmark S&P 500 touched a record high on Thursday, boosted by strong gains in Nvidia, while investors assessed the recent economic data and commentary from Federal Reserve officials to gauge the timing for interest rate cuts this year.
G
K
N
A
U
U
D
D
Reuters - 4 linggo ang nakaraan

Darden Restaurants up after upbeat Q4 profit

BUZZ-Darden Restaurants up after upbeat Q4 profit ** Shares of Olive Garden parent Darden Restaurants DRI.N up ~1% at $153.90 premarket ** Co logs quarterly adj. profit of $2.65 per share vs analysts' estimates of $2.61 per share owing to lower labor costs and marketing expenses ** Same-store sales at LongHorn Steakhouse business rose 4% vs 2.3% ri
D
Reuters - 4 linggo ang nakaraan

Olive Garden-owner Darden beats estimates for quarterly profit

Olive Garden-owner Darden beats estimates for quarterly profit June 20 - Darden Restaurants DRI.N beat market expectations for fourth-quarter profit on Thursday, as higher menu prices and lower wages more than offset rising costs of meat and cooking ingredients, sending its shares up 3% in premarket trading. The Orlando, Florida-based company said menu prices were steadily pushed up to soften the blow of sticky inflation, while its high-end chains, Olive Garden and LongHorn Steakhouse, continued
S
D
Reuters - 4 linggo ang nakaraan

Darden Q4 Adjusted EPS Continuing Operations USD 2.65 Vs. IBES Estimate USD 2.61

BRIEF-Darden Q4 Adjusted EPS Continuing Operations USD 2.65 Vs. IBES Estimate USD 2.61 Jun 20 (Reuters) - Darden Q4 sales USD 3,000 million vs. IBES estimate USD 2,972 million. Q4 EPS continuing operations USD 2.58
D
Reuters - 4 linggo ang nakaraan

Stocks up as Swiss cut again, BoE eyed; yuan slides

MORNING BID AMERICAS-Stocks up as Swiss cut again, BoE eyed; yuan slides A look at the day ahead in U.S. and global markets from Mike Dolan Wall Street returns from its midweek break to find record high stocks still chomping at the bit, with overseas monetary easing in focus as the Swiss cut interest rates for the second time this year and the Bank of England decision now awaited.
C
G
K
M
N
T
U
U
J
U
U
F
A
D
Reuters - 4 linggo ang nakaraan

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M
Reuters - 4 linggo ang nakaraan

Darden Restaurants Inc <DRI.N> expected to post earnings of $2.61 a share - Earnings Preview

Darden Restaurants Inc expected to post earnings of $2.61 a share - Earnings Preview Darden Restaurants Inc DRI.N , DRI is expected to show a rise in quarterly revenue when it reports results on June 20 for the period ending May 31 2024 The Orlando Florida-based company is expected to report a 7.4% increase in revenue to $2.973 billion from $2.77 billion a year ago, according to the mean estimate from 22 analysts, based on LSEG data.The company's guidance on March 21 2024, for the period ended M
D
Reuters - 4 linggo ang nakaraan

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M
Reuters - 1 buwan ang nakaraan

U.S. earnings week ahead

DIARY-U.S. earnings week ahead June 14 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 17-Jun-2024 AMC LEN Lennar Corp Q2 2024 Lennar Corp Earnings Release 20-Jun-2024 BMO KR Kroger Co Q1 2024 Kroger Co Earnings Release 20-Jun-2024 BMO JBL Jabil Inc Q3 2024 Jabil Inc Earnings Release 20-Jun-2024 BMO DRI Darden Restaurants Inc Q4 2024
K
U
C
D
Reuters - 1 buwan ang nakaraan

U.S. Adobe, Oracle, Zscaler

U.S. RESEARCH ROUNDUP-Adobe, Oracle, Zscaler June 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Oracle Corp and Zscaler, on Friday. HIGHLIGHTS * Adobe Inc ADBE.O : Baird raises target price to $545 from $525 * Bandwidth Inc BAND.O : Morgan Stanley cuts to underweight from equal-weight * Corpay Inc CPAY.N : Jefferies cuts target price to $295 from $330 * Oracle Corp ORCL.N : Berenberg raises target price t
A
A
A
B
H
H
M
B
C
D
Reuters - 1 buwan ang nakaraan

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L
Reuters - 1 buwan ang nakaraan

U.S. BioNTech, Honeywell International, Klaviyo

U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday. HIGHLIGHTS * BioNTech SE BNTX.O : JP Morgan raises target price to $94 from $90 * Honeywell International Inc HON.O : HSBC raises target price to $235 from $200 * Klaviyo Inc KVYO.N : Barclays raises to overweight from equal weight * NetA
A
F
G
N
R
G
D
M
Reuters - 1 buwan ang nakaraan

U.S. Biomea Fusion, Enphase Energy, Perion Network

U.S. RESEARCH ROUNDUP-Biomea Fusion, Enphase Energy, Perion Network June 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Biomea Fusion, Enphase Energy and Perion Network, on Tuesday. HIGHLIGHTS * Biomea Fusion Inc BMEA.O : Truist Securities cuts to hold from buy * Cleveland-Cliffs Inc CLF.N : JP Morgan cuts to neutral from overweight * Enphase Energy Inc ENPH.O : HSBC raises to buy from hold * Perion Network Ltd PER
A
G
H
I
M
M
N
V
W
D
Reuters - 2 buwan ang nakaraan

U.S. Autodesk, Equinix, Texas Roadhouse

U.S. RESEARCH ROUNDUP-Autodesk, Equinix, Texas Roadhouse May 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, Equinix and Texas Roadhouse, on Tuesday. HIGHLIGHTS * Autodesk Inc ADSK.O : RBC cuts target price to $260 from $320 * Equinix Inc EQIX.O : RBC cuts target price to $922 from $950 * Huntington Bancshares Inc HBAN.O : JP Morgan raises to overweight from neutral * Viking Holdings Ltd VIK.N : JP Morga
A
C
H
S
U
A
D
K
Reuters - 2 buwan ang nakaraan

U.S. Ameriprise Financial, Dell Technologies, Stryker

U.S. RESEARCH ROUNDUP-Ameriprise Financial, Dell Technologies, Stryker May 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ameriprise Financial, Dell Technologies and Stryker, on Wednesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : Jefferies raises target price to $500 from $487 * Bio-Techne Corp TECH.O : Citigroup cuts to neutral from buy * Dell Technologies Inc DELL.N : Raymond James raises target price to $
A
A
C
C
U
D
G
A
A
D
I
K
L
Reuters - 2 buwan ang nakaraan

U.S. STOCKS Cracker Barrel, Robinhood Markets, DuPont

BUZZ-U.S. STOCKS ON THE MOVE-Cracker Barrel, Robinhood Markets, DuPont Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were little changed on Friday as investors took a breather from the week's rally driven by growing expectations of U.S.
A
C
C
G
R
S
A
L
T
U
U
U
A
D
L

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.